We think that CBX6 reduces the tumor immune response of patients with bladder cancer by suppressing the polarization of M1 macrophages and by attracting a significant number of Tregs, resulting in a poor prognosis for these patients. The gene discussed is CBX6; the disease is urinary bladder cancer.